Products You May Like
Dr. Anthony Fauci (L), director of the National Institute of Allergy and Infectious Diseases speaks as US President Donald Trump meets with Louisiana Governor John Bel Edwards(D-LA) in the Oval Office of the White House in Washington, DC on April 29, 2020.
Mandel Ngan | AFP | Getty Images
White House health advisor Dr. Anthony Fauci said Wednesday that data from a coronavirus drug trial testing Gilead Sciences‘ antiviral drug remdesivir showed “quite good news.”
Speaking to reporters from the White House, Fauci said he was told data from the trial showed ”clear cut positive effect in diminishing time to recover.”
U.S. health officials are expected to release the full results of a drug trial conducted by the National Institute of Allergy and Infectious Diseases later Wednesday. Gilead Sciences announced earlier in the day that the study had met its primary endpoint, but did not provide further details.
This is a developing story. Please check back for updates.